Table of Contents What Cagrilintide and Retatrutide Are and How They Work Approved Uses and Current Clinical Evidence in the UK How These Medicines May Affect Men Specifically Dosage, Administration, and What to Expect Side Effects, Risks, and Safety Considerations Availability on the NHS and Next Steps for Treatment Scientific References Frequently Asked Questions What Cagrilintide and Retatrutide Are and How They Work Cagrilintide is a long-acting amylin analogue that promotes satiety and slows gastric emptying, while retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors to reduce appetite, enhance insulin secretion, and increase energy expenditure
M., van der Pol, W
doi:10.1016/j.rbmo.2020.06.014
They are essential biological tools for daily cellular repair and long term vitality
Yes, when administered by trained professionals, they are very safe with minimal side effects
Healthy ageing and longevity support By reducing senescent cell burden, FOXO4-DRI may delay tissue decline, reduce chronic inflammation, improve organ resilience, and thus extend health-span (time lived in good health)